Frequency Specific Microcurrent for the Treatment of Diastasis Recti

Stopped early · Not applicable · Has a placebo group

Conditions studied: Diastasis Recti

In brief

Determine if frequency specific microcurrent therapy improves pain management of DRA by 30% or greater.

Key facts

Study ID

NCT04060563

Run by

Diana Trang

People needed

13

Starts

2020-01-01

Expected to finish

2021-07-07

Last updated by the study team

2024-04-02

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Active Duty and DoD beneficiary Postpartum Females (12 hours to 24 hours) with Diastasis Rectus Abdominus (DRA) pain
• Aged 18 years or older
• Singleton gestation/delivered (one baby carried and born)
• Vaginal delivery
• Nulliparous (first pregnancy) or multiparous (more than one pregnancy in the past)

You may not qualify if…

• less than 18 years of age
• females greater than 24 hours post-partum
• Medical history to include pacemaker
• History of arrhythmia
• Transplant status
• Insulin pump
• Pain pump
• Active cancer
• Inability to measure IRD
• Delivery via caesarean section
• Operative vaginal delivery (vacuum or forceps)
• 3rd or 4th degree vaginal laceration

Where it is running

• Mike O'Callaghan Military Medical Center — Nellis Air Force Base, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.